During the past decade, Endodigest Clinica Medicala conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Endodigest Clinica Medicala" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Endodigest Clinica Medicala" are "Type 2 Diabetes" (3 trials), "Coronary Heart Disease (CHD)" (1 trials), "Myocardial Infarction" (1 trials), "Obesity" (1 trials) and "Overweight" (1 trials). Many other conditions were trialed in "Endodigest Clinica Medicala" in a lesser frequency.

Most popular intervention types in "Endodigest Clinica Medicala" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Tirzepatide" (5 trials), "Placebo" (3 trials), "Dulaglutide" (2 trials), "Antihyperglycemic medication" (1 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Endodigest Clinica Medicala" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Endodigest Clinica Medicala". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Endodigest Clinica Medicala, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Endodigest Clinica Medicala, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".